Priorities in the Cardiovascular Care of Breast Cancer Survivors

Area of Science:

• Oncology
• Cardiology
• Public Health

Background:

• Breast cancer is the most common cancer in women, with over 3 million survivors in the U.S.
• Breast cancer survivors experience a significant increase in cardiovascular risk factors and disease.
• Cancer therapies, including chemotherapy and radiation, contribute to cardiovascular complications.

Purpose of the Study:

• To review the epidemiology of cardiovascular disease in breast cancer survivors.
• To examine cardiovascular concerns associated with cancer therapies.
• To discuss strategies for early detection, treatment, and prevention of cardiovascular disease in this population.

Main Methods:

• Literature review of epidemiological studies, clinical trials, and observational data.
• Analysis of cardiovascular risks linked to specific breast cancer treatments.
• Evaluation of diagnostic tools (prediction algorithms, biomarkers, imaging) and therapeutic interventions.

Main Results:

• Breast cancer survivors have a higher prevalence of cardiovascular risk factors and established cardiovascular disease.
• Cardiotoxicity is a significant concern with various breast cancer therapies.
• Multidisciplinary approaches are essential for managing cardiovascular health in survivors.

Conclusions:

• There is a critical need for improved cardiovascular risk assessment and management in breast cancer survivors.
• Early detection and intervention strategies, including cardioprotective therapies, can mitigate cardiovascular complications.
• Further evidence-based research is required to optimize the long-term cardiovascular care of breast cancer survivors.